This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - The analyst’s summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
Highlights
Stada Arzneimittel AG, a subsidiary of Nidda Healthcare GmbH (Stada), is a producer of consumer healthcare, generics, and specialty pharmaceutical products. Its major products include medicines for cough and cold, dermatology, pain and relief, vitamins, minerals, gastric issues, sleep, immunology, nephrology, women's and men's health, bone health, neurology, oncology, ophthalmology, and biosimilars. The company also distributes products of other pharmaceutical companies. It offers products to a wide range of customers and patients through brands such as Nizoral, Zoflora, Grippostad, SNUP, Silomat, and Hirudoid, among others, in Asia, the Middle East, and Europe. Stada is headquartered in Bad Vilbel, Hessen, Germany.Stada Arzneimittel AG Key Recent Developments
- Sep 28, 2026: STADA and SBP Group Launch Strategic Biosimilars Partnership Including Pembrolizumab Biosimilar
- Sep 09, 2026: STADA Pymepharco Ho Chi Minh City Office to Relocate
- Sep 07, 2026: STADA Appoints Diana Wiedmann as Chief Culture and People Officer
- Jul 01, 2026: STADA Welcomes Former Reckitt Executive Mark Pearson as Global Head Consumer Healthcare
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with the analyst’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- MPA Pharma GmbH
- Teva Pharmaceutical Industries Ltd
- MorphoSys AG
- Bayer AG
- Sandoz Group AG
- Reckitt Benckiser Group Plc
- MediGene AG
- Laboratorios Cinfa SA
- Evotec SE
- EGIS Pharmaceuticals Plc
- Fresenius Kabi AG
- Aurobindo Pharma Ltd
- Sanofi
- Les Laboratoires Servier SAS
- Laboratorios Normon SA
- Kenvue Inc
- Biotest GmbH & Co KGaA
- Zentiva SA
- Haleon Plc
- Viatris Inc

